Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency
Marco Gatti, Ralph Imhof, Qingyao Huang, et al.
Cell Reports (2020) Vol. 32, Iss. 5, pp. 107985-107985
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 515
The therapeutic potential of targeting regulated non-apoptotic cell death
Kamyar Hadian, Brent R. Stockwell
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 723-742
Closed Access | Times Cited: 171
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
Priyanka Verma, Yeqiao Zhou, Zhendong Cao, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 2, pp. 160-171
Open Access | Times Cited: 122
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin
Dragomir B. Krastev, Shudong Li, Yilun Sun, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 1, pp. 62-73
Open Access | Times Cited: 112
Protein post-translational modifications in the regulation of cancer hallmarks
Haiying Wang, Liqian Yang, Minghui Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 529-547
Closed Access | Times Cited: 79
Leveraging the replication stress response to optimize cancer therapy
Emily Cybulla, Alessandro Vindigni
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 6-24
Open Access | Times Cited: 70
Biology-driven therapy advances in high-grade serous ovarian cancer
Yinu Wang, Alexander James Duval, Mazhar Adli, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 1
Open Access | Times Cited: 21
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, et al.
European Journal of Cancer (2021) Vol. 149, pp. 134-152
Closed Access | Times Cited: 56
Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates
Fredrik Trulsson, Vyacheslav Akimov, Mihaela Robu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer
Xiaoxiang Sun, Huanyin Tang, Yu Chen, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 716-733
Closed Access | Times Cited: 29
Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Daniela Spano, Giuliana Catara
Cells (2023) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 26
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance
Petar-Bogomil Kanev, Aleksandar Atemin, Stoyno Stoynov, et al.
Seminars in Oncology (2023) Vol. 51, Iss. 1-2, pp. 2-18
Open Access | Times Cited: 25
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification
Élise Rouleau-Turcotte, John M. Pascal
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105397-105397
Open Access | Times Cited: 25
DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids
Kang Zhu, Marcin J. Suskiewicz, Chatrin Chatrin, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 2, pp. 801-815
Open Access | Times Cited: 24
Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection
Julie Rageul, Natalie Lo, Amy L Phi, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113845-113845
Open Access | Times Cited: 10
A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells
Petar-Bogomil Kanev, Sylvia Varhoshkova, Irina Georgieva, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114234-114234
Open Access | Times Cited: 10
Damage-induced chromatome dynamics link Ubiquitin ligase and proteasome recruitment to histone loss and efficient DNA repair
Kiran Challa, Christoph D. Schmid, Saho Kitagawa, et al.
Molecular Cell (2021) Vol. 81, Iss. 4, pp. 811-829.e6
Open Access | Times Cited: 49
Reconstitution of the DTX3L–PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly
Yashwanth Ashok, Carlos Vela‐Rodríguez, Chunsong Yang, et al.
Biochemical Journal (2022) Vol. 479, Iss. 3, pp. 289-304
Open Access | Times Cited: 34
TSG101 associates with PARP1 and is essential for PARylation and DNA damage‐induced NF‐κB activation
Ahmet Buğra Tufan, Katina Lazarow, Marina Kolesnichenko, et al.
The EMBO Journal (2022) Vol. 41, Iss. 21
Open Access | Times Cited: 29
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA -mutated cancer
Peng Li, Yuanli Zhen, Chiho Kim, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 20
PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway
Jiangchun Wu, Yong Wu, Siyu Chen, et al.
Oncogene (2024) Vol. 43, Iss. 12, pp. 866-883
Closed Access | Times Cited: 8
Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis
Yinyin Shu, Xiaoni Jin, Mintao Ji, et al.
Cancer Research (2024) Vol. 84, Iss. 17, pp. 2836-2855
Closed Access | Times Cited: 8
E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions
Manon Brunet, Claire Vargas, Dorian Larrieu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8515-8515
Open Access | Times Cited: 47
The CDK1-TOPBP1-PLK1 axis regulates the Bloom’s syndrome helicase BLM to suppress crossover recombination in somatic cells
Chiara Balbo Pogliano, Ilaria Ceppi, Sara Giovannini, et al.
Science Advances (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 25
The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
Jaromir Hunia, Karol Gawalski, Aleksandra Szredzka, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top